Boston, MA
United States
Harvard University - Dana-Farber Cancer Institute
acquired resistance, platinum-based chemotherapy, CTLA-4 inhibitors, immunotherapy, non-small cell lung cancer
Non-Small Cell Lung Cancer, immunotherapy, pembrolizumab, Tumor microenvironment, Tumor immunophenotype, Older adults
Computational Pathology, Whole Slide Images, Deep learning, Tissue Artifacts, Histology